packageInfliximab

infliximab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Infliximab is a monoclonal antibody that blocks tumour necrosis factor alpha and is used to treat inflammatory conditions such as rheumatoid and psoriatic arthritis, Crohn's disease, ulcerative colitis, psoriasis, and ankylosing spondylitis. It is approved and widely used, with several products authorised in the European Union, and is also being studied for other uses.

Summary written by glm-5.3-flash from Wikidata Q415264 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:infliximab
ATC codes:L04AB02
DrugBank:DB00065
Wikidata:Q415264
molar mass:144190 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown